Dagmar Rossner

Suggest Changes
Learn More
Neurotoxicity is a common side effect of platinum/taxane-based therapy of ovarian cancer. We performed a double-blind randomized placebo-controlled trial to evaluate the influence of the(More)
804 Background: Immunetherapy with trastuzumab (TR, herceptin, Roche), a selective HER-2(ErbB2)-antibody, is approved in women with metastatic breast cancer (MBC). During TR monotherapy(More)